logo
Share SHARE
FONT-SIZE Plus   Neg

AllThingsD: Groupon Board Mulls CEO Change

Groupon Inc.'s (GRPN) board of directors is considering making major possible leadership changes at the struggling daily deal website due to increasing frustration at the performance of co-founder and chief executive officer Andrew Mason, according to technology blog AllThingsD on Tuesday.

According to the report, some of the directors plan to voice their concerns about Mason at a regularly scheduled board meeting later this week amid slowing growth and stock decline. However, a change may not happen immediately.

In early November, Chicago, Illinois-based Groupon reported a loss for the third quarter that narrowed from last year on strong revenue growth. However, the company's investors were not impressed with the results, as the top-line growth was slower than previous quarters.

Groupon's international revenues continued to be impacted by economic weakness in Europe. The company, which has a business model that is easy to imitate, has also been affected by imitators such as LivingSocial and Amazon Local.

Groupon's shares plunged 87 percent to a record low of $2.63 in November, compared to its IPO price of $20 per share in November 2011. The company's IPO was said to be the biggest ever public offer by a U.S.-based internet company after Google Inc. (GOOG) raised about $1.9 billion in 2004.

Groupon had reported several accounting issues prior to going public and amended details of its financial information last year. The company twice revised its financial results before its November 2011 IPO.

In mid-November, hedge fund Tiger Global Management said it has acquired a 9.9 percent stake in Groupon even as the company's stock traded near all-time lows since it went public in November last year.

GRPN closed Tuesday's regular trading session at $3.96, up $0.16 or 4.07 percent on a volume of 12.41 million shares. In after-hours, the stock further gained $0.15 or 3.79 percent to $4.11.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves. Major League Baseball is talking expansion for the first time in a few decades. Owners stand to make a pretty penny from expansion fees and subsequent television rights. The possibility of a more balanced schedule is also enticing. Strong expansion candidates in the U.S. and Canada are ready... The New York Times is teaming up with Google again to give away Google Cardboard, the virtual reality headsets, but this time only to its "most loyal" digital subscribers. The company said that the digital-only subscribers selected for this distribution were chosen based on the duration of their subscriptions.
comments powered by Disqus
Follow RTT